Hexagon Capital Partners LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 307 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Hexagon Capital Partners LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2024$42,573
-33.4%
3,290
-28.6%
0.01%
-35.7%
Q1 2024$63,963
-3.0%
4,605
-0.3%
0.01%
-12.5%
Q4 2023$65,928
-23.2%
4,620
-16.7%
0.02%
-27.3%
Q3 2023$85,828
+63.1%
5,548
+65.7%
0.02%
+57.1%
Q2 2023$52,613
-25.0%
3,349
-21.3%
0.01%
-30.0%
Q1 2023$70,139
+15.9%
4,256
+9.7%
0.02%
+11.1%
Q4 2022$60,512
-0.8%
3,879
-17.7%
0.02%0.0%
Q3 2022$61,000
+281.2%
4,716
+311.2%
0.02%
+260.0%
Q2 2022$16,0001,1470.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2023
NameSharesValueWeighting ↓
Y.D. More Investments Ltd 1,498,811$24,700,3805.57%
TFG Asset Management GP Ltd 1,903,662$31,372,3504.20%
Clean Yield Group 542,342$8,937,7963.81%
MANAGED ASSET PORTFOLIOS, LLC 1,467,952$24,1923.67%
Mondrian Investment Partners LTD 4,081,715$67,266,6631.48%
Sippican Capital Advisors 82,235$1,355,2331.30%
Psagot Value Holdings Ltd. / (Israel) 174,300$2,8301.18%
Clal Insurance Enterprises Holdings Ltd 4,365,500$71,9431.08%
Legacy Wealth Asset Management, LLC 123,303$2,032,0330.73%
BRANDES INVESTMENT PARTNERS, LP 1,817,972$29,960,1750.64%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders